A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)
Clinical trial NCT04438304 · COMPLETED
Trial details
- NCT number
- NCT04438304
- Sponsor
- Clarity Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-02
- Primary completion
- 2024-11-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.